WPI (Raloxifene Hydrochloride 60 mg)
Pill with imprint WPI is White, Elliptical / Oval and has been identified as Raloxifene Hydrochloride 60 mg. It is supplied by Actavis Pharma, Inc..
Raloxifene is used in the treatment of prevention of osteoporosis; breast cancer, prevention; osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Raloxifene 60 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI
Raloxifene Hydrochloride
- Imprint:
- WPI
- Strength:
- 60 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Hormones/antineoplastics
Selective estrogen receptor modulators - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-2367
More about raloxifene
- Raloxifene Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: hormones/antineoplastics
- FDA Alerts (1)
Consumer resources
Other brands: Evista
Professional resources
- Raloxifene Hydrochloride (AHFS Monograph)
- Raloxifene Hydrochloride Tablets (FDA)
- Raloxifene (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
